Skip to content
Loading…
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on The Guardian.